chemotherapy training level 1 essex cancer network october 2012
TRANSCRIPT
![Page 1: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/1.jpg)
Chemotherapy TrainingLevel 1
Essex Cancer NetworkOctober 2012
![Page 2: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/2.jpg)
INTRODUCTION
![Page 3: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/3.jpg)
Why?
Level One training is required for all staff who may come across chemotherapy in their normal job, such as dispensary technicians, assistants and aseptics staff.
Level Two training is for all staff involved in prescription verification of SACT prescriptions.
Level Three training is for specialist oncology staff, who work within the area of cancer for more than 50% of their time, or are designated as a cancer specialist at their trust.
![Page 4: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/4.jpg)
Principles for Level One Training
Knowledge •Basic background knowledge of cancerTraining •One hour lunchtime session held each year. Key elements of syllabus•Health and safely/ safe handling•Relevant protocols/SOPs to trust•Labelling•Counselling•Where to go for further advice•Background and principles of chemotherapyRevalidation •To be revalidated the individual must attend a yearly update in oncology training session.
![Page 5: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/5.jpg)
CANCER
![Page 6: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/6.jpg)
6
Background knowledge of cancer
• Cancer– Abnormal growth of cells which tend to proliferate in an
uncontrolled way and may spread – Derived from Greek word karkinos meaning crab
• Tumour– Latin word meaning “abnormal swelling”
• Neoplasm– “new growth” (benign or malignant)
• Benign– Not cancer– Does not invade surrounding tissue or spread to other parts
of the body.
![Page 7: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/7.jpg)
7
Background knowledge of cancer
• Malignant– Tending to be severe and become progressively worse– Can invade and destroy nearby tissue and that may spread to
other parts of the body. – Latin combination of "mal" meaning "bad" and "nascor"
meaning "to be born“ – literally means "born to be bad" • Oncology
– Branch of medicine that deals with cancer, including study of their development, diagnosis, treatment, and prevention
• Haematology– Branch of medicine that specialises in study & treatment of
blood
![Page 8: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/8.jpg)
8
Cancer Treatment Choices
• Can be used alone or in combination – to enhance local control & attack potential sites of metastases
• Systemic therapy– Chemotherapy– Hormone therapy– Biological therapy– Experimental chemotherapy
![Page 9: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/9.jpg)
CHEMOTHERAPY
![Page 10: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/10.jpg)
Principles of chemotherapy
“Normal cells obey strict rules.Divide only when told.
Die rather than misbehave.”• Normal cells have several systems for
interrupting the cell cycle if there is a problem• These control systems are called
“checkpoints”• Checkpoints are biological traffic lights telling
the cell when it can safely carry on to replicate or when to stop and fix a problem
![Page 11: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/11.jpg)
Principles of chemotherapy
• In cancer cells, some or all of the usual checkpoints fail leading to an over proliferation of abnormal cells
• The faulty checkpoints make the cell unable to check if the DNA replication was complete, if any mutations needed to be repaired, if the DNA was properly separated between the daughter cells, or many other problems
• These cells are likely to become cancerous with their multiple genomic problems
Whereas normal cells have functioning checkpoints, abnormal cells checkpoints have
been lost or disabled
![Page 12: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/12.jpg)
12
Aim of Systemic Chemotherapy
• Cure– Cancer / Tumour disappears and does not return
• Control– If cure is not possible, the goal is to control the disease (stop
growth & spreading)
• Palliation– For advanced cancer, where control is unlikely. Drugs used to
relieve symptoms Improve QoL
![Page 13: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/13.jpg)
Why in ‘regimens’
• Combination chemotherapy is used to try and improve rate and duration of response by combining drugs with different mechanisms of action:– helps to prevent resistance– known to be effective as single agents– different toxicity (toxicities don’t overlap)– try to use drugs with synergistic killing effect– no clinically important drug interactions between the
agents
![Page 14: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/14.jpg)
Why in courses?
• Use pulsed intermittent therapy to allow normal cells to recover
• Normal (bone marrow cells) cells recover quicker from chemotherapy then cancer cells
• Normal tissues are inevitably damaged by chemotherapy – bone marrow & epithelial lining cells usually recover within 2-3 weeks
• On this basis, most chemotherapy given at 3 – 4 weekly intervals
![Page 15: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/15.jpg)
15
Time (Weeks)
Frac
tion
Cell
Surv
ived
3 60
Bone Marrow Cells
Tumour CellsCourse of treatment
Limit of detection
Relapse
Pulsed therapy
![Page 16: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/16.jpg)
Mucositis
Nausea/vomiting
Diarrhea
Cystitis
Sterility
Neuropathy
Common Side Effects
Alopecia
Pulmonary fibrosis
Cardiotoxicity
Local reaction
Renal failure
Myelosuppression
![Page 17: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/17.jpg)
ORAL CHEMOTHERAPY
![Page 18: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/18.jpg)
NPSA RRR Risks of incorrect dosing of oral
anti-cancer medicines – 22 January 2008• Doctors, nurses, pharmacists and their staff
must be made aware that the – Prescribing– Dispensing, and– Administration
of oral anti-cancer medicines should be carried out and monitored to the same standard as injected therapy.
![Page 19: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/19.jpg)
NPSA RRR Risks of incorrect dosing of oral
anti-cancer medicines – 22 January 2008
Oral anti-cancer medicine - incidents by type of medication error
51%
9%
17%
23%Wrong dose, strength,frequency, quantity
Wrong drug / medicine
Omitted medicine
Other
![Page 20: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/20.jpg)
Principles for Safe Dispensing
• Prescriptions must be screened by an authorised pharmacist
• All pharmacy staff involved with dispensing oral anticancer agents must have access to full copies of all relevant protocols (trial and non-trial)
• Dispensary staff must have ready access to specialist oncology pharmacy advice
• Dispensary staff should work to detailed operational procedures
• Label directions must be clear and unambiguous – where relevant include treatment period, start and stop dates and an indication of the need for safe handling
![Page 21: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/21.jpg)
Principles for Safe Dispensing
• Patient information leaflets may be supplemented with additional local information
• For patients with swallowing difficulties, there is a need to seek specialist advice (medicines information or oncology pharmacist)
• General risk management issues such as handling of wastage from patients, inappropriate storage and risk to others, especially young children should be given
![Page 22: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/22.jpg)
HEALTH AND SAFETY
![Page 23: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/23.jpg)
Health and safely
Chemotherapy is:– Mutagenic
• induces mutations
– Teratogenic• disturbs the growth of embryo/foetus
– Carcinogenic • causes cancer, changes normal cells into cancerous
cells
![Page 24: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/24.jpg)
Routes of Absorption
• Inhalationaerosols or evaporation
• Absorptionskin or mucous membranes
• Ingestion
hand to mouth contact
![Page 25: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/25.jpg)
Methods of Exposure
• Direct contact with cytotoxicsSpillageSplashNeedle-stickAerosol Picking them up
Therefore made up in aseptics in ‘isolators’
![Page 26: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/26.jpg)
![Page 27: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/27.jpg)
Oral Chemotherapy
• Should not be touched by hand• Use cytotoxic triangle to count - Do not use
medicines counter• The tablet/capsule should be placed into a
medicine cup or spoon and taken by the patient directly from the container without handling
• For patients with swallowing difficulties, there is a need to seek specialist advice on crushing tablets or opening capsules (medicines information or oncology pharmacist)
![Page 28: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/28.jpg)
NEED TO KNOWs
![Page 29: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/29.jpg)
Relevant protocols/SOPs to trust
• Please list for your trust
![Page 30: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/30.jpg)
Labelling
• Label directions must be clear and unambiguous – where relevant include treatment period, start and stop dates and an indication of the need for safe handling
• All labels for chemotherapy agents (not TKIs/MABs) must have stated – ‘Cytotoxic – handle with care’
![Page 31: Chemotherapy Training Level 1 Essex Cancer Network October 2012](https://reader031.vdocument.in/reader031/viewer/2022032803/56649e265503460f94b159ad/html5/thumbnails/31.jpg)
Counselling
• Unless you have had specific training on chemotherapy agents to level 2 or 3, you should not counsel patients about taking their chemotherapy agents.
• If you need further advise please contact your specialist cancer pharmacist